Author Correction: Experimental study on thioredoxin redox inhibitor 1-methylpropyl 2-imidazolyl disulfide promoting apoptosis of multiple myeloma cells in vitro and in vivo

Q.-D. Lin, L.-N. Liu, X.-Y. Liu, Y. Yan, B.-J. Fang, Y.-L. Zhang, J. Zhou, Y.-F. Li, W.-L. Zuo, Y.-P. Song

Henan Key Lab of Experimental Hematology, Henan Institute of Hematology, Henan Cancer Hospital, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China

---

• Oncology

Correction to: European Review for Medical and Pharmacological Sciences 2022; 26 (4): 1283-1292. DOI: 10.26355/eurrev_202202_28121-PMID: 35253185-published online on December 15, 2022.

After publication, the authors corrected the order of the author’s affiliations as follows:

Q.-D. Lin^1,2,3,4, L.-N. Liu^1,2,3,4, X.-Y. Liu^1,2, Y. Yan^1,2, B.-J. Fang^1,2,3,4, Y.-L. Zhang^1,2,3,4, J. Zhou^1,2,3,4, Y.-F. Li^1,2,3,4, W.-L. Zuo^1,2,3,4, Y.-P. Song^1,2,3,4

¹Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China

²Henan Cancer Hospital, Zhengzhou City, Henan Province, China

³Henan Key Lab of Experimental Hematology, Zhengzhou City, Henan Province, China

⁴Henan Institute of Hematology, Zhengzhou City, Henan Province, China

 

There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.

Experimental study on thioredoxin redox inhibitor 1-methylpropyl 2-imidazolyl disulfide promoting apoptosis of multiple myeloma cells in vitro and in vivo

 

Free PDF Download